Join the ICBR Gene Expression & Genotyping core and Mission Bio for a special in-person event where we highlight the key advantages of single-cell technology that simultaneously measures SNVs, CNVs, and surface protein changes from the same cells.
Quantitative characterization of genotype and immunophenotype at the single-cell level reveals clonal phylogeny and selection at higher resolution, ultimately improving personalized therapeutic selection. By revealing co-occurrence and zygosity of mutations in single cells, Tapestri enables comprehensive insights into disease progression, development of therapy resistance, and MRD.
We’ll provide an introduction to Tapestri’s capabilities and workflow and discuss the utility of single-cell multiomics in heme malignancies, solid tumor cancers, therapy resistance as well as cell & gene therapy.
4 сен 2024
